Post by
newdaydawning on Mar 31, 2019 10:12pm
Which stock will double first? FIRE or PAS?
Cannabis investors looking for a new twist should have a gander at Pascal Biosciences (PAS). This is a pure cannnabinoid science play that has isolated phyto-cannabinoid molecules that enhance the immune systems ability to combat cancer. PAS has also developed synthetic cannabinoids that show great promise in the treatment of the most lethal form of brain cancer - glioblastoma.
PAS is currently bouncing off its 52-week low, with a paltry $12.5M valuation. Looking for a better chance for a double compared to that offered by most weed growers, including FIRE?
Look no further than PAS.